OpenURL Connection Search

Select item for more details and to access through your institution.

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor– or Progesterone Receptor–Positive Breast Cancer.
Published in:
Clinical Breast Cancer, 2010, v. 10, n. 4, p. 275, doi. 10.3816/CBC.2010.n.035
By:
- Forero-Torres, Andres;
- Saleh, Mansoor N.;
- Galleshaw, Janice A.;
- Jones, Cheryl F.;
- Shah, Jatin J.;
- Percent, Ivor J.;
- Nabell, Lisle M.;
- Carpenter, John T.;
- Falkson, Carla I.;
- Krontiras, Helen;
- Urist, Marshall M.;
- Bland, Kirby I.;
- De Los Santos, Jennifer F.;
- Meredith, Ruby F.;
- Caterinicchia, Valerie;
- Bernreuter, Wanda K.;
- O'Malley, Janis P.;
- Li, Yufeng;
- LoBuglio, Albert F.
Publication type:
Article
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
Published in:
British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
By:
- Samaniego, Felipe;
- Berkova, Zuzana;
- Romaguera, Jorge E.;
- Fowler, Nathan;
- Fanale, Michelle A.;
- Pro, Barbara;
- Shah, Jatin J.;
- McLaughlin, Peter;
- Sehgal, Lalit;
- Selvaraj, Vijairam;
- Braun, Frank K.;
- Mathur, Rohit;
- Feng, Lei;
- Neelapu, Sattva S.;
- Kwak, Larry W.
Publication type:
Article
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
Published in:
British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
By:
- Samaniego, Felipe;
- Berkova, Zuzana;
- Romaguera, Jorge E.;
- Fowler, Nathan;
- Fanale, Michelle A.;
- Pro, Barbara;
- Shah, Jatin J.;
- McLaughlin, Peter;
- Sehgal, Lalit;
- Selvaraj, Vijairam;
- Braun, Frank K.;
- Mathur, Rohit;
- Lei Feng;
- Neelapu, Sattva S.;
- Kwak, Larry W.
Publication type:
Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.
Published in:
Oncology (08909091), 2013, v. 27, p. 1
By:
- Shah, Jatin J.
Publication type:
Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.
Published in:
Oncology (08909091), 2013, v. 27, p. 1
By:
- Shah, Jatin J.
Publication type:
Article
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function.
Published in:
Clinical Pharmacology, 2017, v. 9, p. 133, doi. 10.2147/CPAA.S144606
By:
- Yan Li;
- Xiaomin Wang;
- O’Mara, Edward;
- Dimopoulos, Meletios A.;
- Sonneveld, Pieter;
- Weisel, Katja C.;
- Matous, Jeffrey;
- Siegel, David S.;
- Shah, Jatin J.;
- Kueenburg, Elisabeth;
- Sternas, Lars;
- Cavanaugh, Chloe;
- Zaki, Mohamed;
- Palmisano, Maria;
- Zhou, Simon
Publication type:
Article
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
Published in:
European Journal of Haematology, 2016, v. 97, n. 4, p. 342, doi. 10.1111/ejh.12736
By:
- Badar, Talha;
- Cornelison, Amanda Megan;
- Shah, Nina D.;
- Bashir, Qaiser;
- Parmar, Simrit;
- Patel, Krina;
- Hosing, Chitra;
- Popat, Uday;
- Weber, Donna M.;
- Thomas, Sheeba K.;
- Shah, Jatin J.;
- Orlowski, Robert Z.;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.
Publication type:
Article
Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
Published in:
Science Translational Medicine, 2016, v. 8, n. 353, p. 1, doi. 10.1126/scitranslmed.aad8949
By:
- Huan Liu;
- Zhiqiang Liu;
- Juan Du;
- Jin He;
- Pei Lin;
- Amini, Behrang;
- Starbuck, Michael W.;
- Novane, Nora;
- Shah, Jatin J.;
- Davis, Richard E.;
- Jian Hou;
- Gagel, Robert F.;
- Jing Yang
Publication type:
Article
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Published in:
2020
By:
- Kaufman, Jonathan L.;
- Mina, Roberto;
- Shah, Jatin J.;
- Laubach, Jacob P.;
- Nooka, Ajay K.;
- Lewis, Colleen;
- Gleason, Charise;
- Sharp, Cathy;
- Harvey, R. Donald;
- Heffner, Leonard T.;
- Richardson, Paul;
- Lonial, Sagar;
- Orlowski, Robert Z.
Publication type:
journal article
Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
Published in:
2017
By:
- Shah, Jatin J.;
- Abonour, Rafat;
- Gasparetto, Christina;
- Hardin, James W.;
- Toomey, Kathleen;
- Narang, Mohit;
- Srinivasan, Shankar;
- Kitali, Amani;
- Zafar, Faiza;
- Flick, E. Dawn;
- Rifkin, Robert M.
Publication type:
journal article
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
Published in:
2016
By:
- Pinnix, Chelsea C.;
- Shah, Jatin J.;
- Chuang, Hubert;
- Costelloe, Colleen M.;
- Medeiros, L. Jeffrey;
- Wogan, Christine F.;
- Reed, Valerie;
- Smith, Grace L.;
- Milgrom, Sarah;
- Patel, Krina;
- Huo, Jinhai;
- Turturro, Francesco;
- Romaguera, Jorge;
- Fayad, Luis;
- Oki, Yasuhiro;
- Fanale, Michelle A.;
- Westin, Jason;
- Nastoupil, Loretta;
- Hagemeister, Fredrick B.;
- Rodriguez, Alma
Publication type:
journal article
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
Published in:
2016
By:
- Jacobs, Ryan W.;
- Saliba, Rima M.;
- Sasaki, Koji;
- Farhan, Shatha;
- Armas, Aristides;
- Shah, Nina D.;
- Bashir, Qaiser;
- Qureshi, Sofia;
- Rondon, Gabriela;
- Hosing, Chitra;
- Popat, Uday;
- Parmar, Simrit;
- Shah, Jatin J.;
- Wang, Michael;
- Weber, Donna M.;
- Thomas, Sheeba K.;
- Orlowski, Robert Z.;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.
Publication type:
journal article
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
Published in:
2015
By:
- Kazmi, Syed M.;
- Nusrat, Maliha;
- Gunaydin, Hilal;
- Cornelison, Amanda M.;
- Shah, Nina;
- Kebriaei, Partow;
- Nieto, Yago;
- Parmar, Simrit;
- Popat, Uday R.;
- Oran, Betul;
- Shah, Jatin J.;
- Orlowski, Robert Z.;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.;
- Bashir, Qaiser
Publication type:
journal article
Impact of Rituximab Treatment on 90Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma.
Published in:
Journal of Nuclear Medicine, 2010, v. 51, n. 1, p. 150, doi. 10.2967/jnumed.109.066597
By:
- Shen, Sui;
- Forero, Andres;
- Meredith, Ruby F.;
- Shah, Jatin J.;
- Knox, Susan J.;
- Wiseman, Gregory A.;
- Usrey, Marc E.;
- Lobuglio, Albert F.
Publication type:
Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Published in:
2019
By:
- Lee, Hans C.;
- Shah, Jatin J.;
- Feng, Lei;
- Manasanch, Elisabet E.;
- Lu, Rebecca;
- Morphey, Ashley;
- Crumpton, Brandon;
- Patel, Krina K.;
- Wang, Michael L.;
- Alexanian, Raymond;
- Thomas, Sheeba K.;
- Weber, Donna M.;
- Orlowski, Robert Z.
Publication type:
Letter
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
By:
- Lee, Hans C.;
- Shah, Jatin J.;
- Feng, Lei;
- Morphey, Ashley;
- Johnson, Ralph J.;
- Wesson, Emily T.;
- Wang, Michael L.;
- Alexanian, Raymond;
- Thomas, Sheeba K.;
- Orlowski, Robert Z.;
- Weber, Donna M.
Publication type:
Article
Recognition of early mortality in multiple myeloma by a prediction matrix.
Published in:
American Journal of Hematology, 2017, v. 92, n. 9, p. 915, doi. 10.1002/ajh.24796
By:
- Terebelo, Howard;
- Srinivasan, Shankar;
- Narang, Mohit;
- Abonour, Rafat;
- Gasparetto, Cristina;
- Toomey, Kathleen;
- Hardin, James W.;
- Larkins, Gail;
- Kitali, Amani;
- Rifkin, Robert M.;
- Shah, Jatin J.
Publication type:
Article
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
Published in:
American Journal of Hematology, 2016, v. 91, n. 10, p. E442, doi. 10.1002/ajh.24487
By:
- Gaballa, Sameh;
- Saliba, Rima M.;
- Srour, Samer;
- Lu, Gary;
- Brammer, Jonathan E.;
- Shah, Nina;
- Bashir, Qaiser;
- Patel, Krina;
- Bock, Fabian;
- Parmar, Simrit;
- Hosing, Chitra;
- Popat, Uday;
- Delgado, Ruby;
- Rondon, Gabriela;
- Shah, Jatin J.;
- Manasanch, Elisabet E.;
- Orlowski, Robert Z.;
- Champlin, Richard;
- Qazilbash, Muzaffar H.
Publication type:
Article
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Published in:
American Journal of Hematology, 2012, v. 87, n. 3, p. 272, doi. 10.1002/ajh.22273
By:
- Bashir, Qaiser;
- Khan, Hassan;
- Orlowski, Robert Z.;
- Amjad, Ali Imran;
- Shah, Nina;
- Parmar, Simrit;
- Wei, Wei;
- Rondon, Gabriela;
- Weber, Donna M.;
- Wang, Michael;
- Thomas, Sheeba K.;
- Shah, Jatin J.;
- Qureshi, Sofia R.;
- Dinh, Yvonne T.;
- Popat, Uday;
- Anderlini, Paolo;
- Hosing, Chitra;
- Giralt, Sergio;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.
Publication type:
Article
Return to the Primary Acute Care Service Among Patients With Multiple Myeloma on an Acute Inpatient Rehabilitation Unit.
Published in:
2017
By:
- Fu, Jack B.;
- Lee, Jay;
- Shin, Ben C.;
- Silver, Julie K.;
- Smith, Dennis W.;
- Shah, Jatin J.;
- Bruera, Eduardo
Publication type:
journal article
A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.
Published in:
2017
By:
- Shah, Jatin J.;
- Kaufman, Jonathan L.;
- Zonder, Jeffrey A.;
- Cohen, Adam D.;
- Bensinger, William I.;
- Hilder, Brandi W.;
- Rush, Selena A.;
- Walker, Duncan H.;
- Tunquist, Brian J.;
- Litwiler, Kevin S.;
- Ptaszynski, Mieke;
- Orlowski, Robert Z.;
- Lonial, Sagar
Publication type:
journal article
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
Published in:
2016
By:
- Mian, Idrees;
- Milton, Denái R.;
- Shah, Nina;
- Nieto, Yago;
- Popat, Uday R.;
- Kebriaei, Partow;
- Parmar, Simrit;
- Oran, Betul;
- Shah, Jatin J.;
- Manasanch, Elisabet E.;
- Orlowski, Robert Z.;
- Shpall, Elizabeth J.;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.;
- Bashir, Qaiser
Publication type:
journal article
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.
Published in:
Cancer (0008543X), 2012, v. 118, n. 9, p. 2507, doi. 10.1002/cncr.26517
By:
- Sharma, Manish;
- Khan, Hassan;
- Thall, Peter F.;
- Orlowski, Robert Z.;
- Bassett, Roland L.;
- Shah, Nina;
- Bashir, Qaiser;
- Parmar, Simrit;
- Wang, Michael;
- Shah, Jatin J.;
- Hosing, Chitra M.;
- Popat, Uday R.;
- Giralt, Sergio A.;
- Champlin, Richard E.;
- Qazilbash, Muzaffar H.
Publication type:
Article
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.
Published in:
British Journal of Haematology, 2011, v. 152, n. 5, p. 579, doi. 10.1111/j.1365-2141.2010.08533.x
By:
- Hunsucker, Sally A.;
- Magarotto, Valeria;
- Kuhn, Deborah J.;
- Kornblau, Steven M.;
- Wang, Michael;
- Weber, Donna M.;
- Thomas, Sheeba K.;
- Shah, Jatin J.;
- Voorhees, Peter M.;
- Xie, Hong;
- Cornfeld, Mark;
- Nemeth, Jeffrey A.;
- Orlowski, Robert Z.
Publication type:
Article

Found: 24

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor– or Progesterone Receptor–Positive Breast Cancer.

<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.

<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.

Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.

Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function.

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.

Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.

Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.

Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.

Impact of Rituximab Treatment on <sup>90</sup>Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma.

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Recognition of early mortality in multiple myeloma by a prediction matrix.

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Return to the Primary Acute Care Service Among Patients With Multiple Myeloma on an Acute Inpatient Rehabilitation Unit.

A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.

Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.